August 5, 2015

Vaccine with Virus-Like Nanoparticles Effective Treatment for RSV, Study Finds

(Nanotechnology Now) – A vaccine containing virus-like nanoparticles, or microscopic, genetically engineered particles, is an effective treatment for respiratory syncytial virus (RSV), according to researchers at Georgia State University. The findings, published on July 14 in the International Journal of … Read More

Recommended Reading